Uncovering this mechanism paves the way for the investigation of therapeutic approaches that target mutant HNRNPH2 transcripts, induce compensatory HNRNPH1 expression, and ultimately alleviate the symptoms of HNRNPH2-associated NDD. The gene discussed is HNRNPH2; the disease is Neurodevelopmental delay.